You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 150 No. 10, October 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Rethinking the Threshold for an Abnormal Capillary Blood Lead Screening Test

James D. Sargent, MD; Madeline A. Dalton, PhD

Arch Pediatr Adolesc Med. 1996;150(10):1084-1088.


Abstract

Objectives
To examine the test characteristics of the capillary blood lead screening test as a predictor of elevated venous blood lead levels, using receiver operating characteristic (ROC) curves. To consider a rational capillary blood lead cutoff value in the context of what has been learned about the screening test and what is understood about the clinical course of children with elevated blood lead levels in the mild range (0.48-0.92 µmol/L [10-19 µg/dL]).

Design
In a clinical trial, 513 urban children aged 6 years and younger were screened for lead exposure. Paired samples of venous blood were drawn from all children. For these children we examine the ROC curves for capillary blood lead levels as a predictor of elevated venous blood lead levels above 2 thresholds, 0.48 and 0.97 µmol/L (10 and 20 µg/dL). Contaminated capillary specimens were defined as those in which the capillary result exceeded the venous result by 0.12 µmol/L (2.5 µg/dL) or more (n=49).

Main Outcome Measures
Test sensitivity and false-positive rate (equal to 1—specificity) as a function of the capillary screening cutoff value. Area under the ROC curve as a measure of screening test performance.

Results
Venous blood lead levels were 0.48 µmol/L (10 µg/dL) or more in 20.5% and 0.97 µmol/L (20 µg/dL) or more in 2.3% of children. Measurement of capillary blood lead levels performed very well as a screening test with an area under the ROC curve of 0.97 at the 0.48-µmol/L (10-µg/dL) threshold and 0.99 at the 0.97-µmol/L (20-µg/dL) threshold. For a capillary cutoff value of 0.39 µmol/L (8 µg/dL) and an elevated blood lead level threshold of 0.48 µmol/L (10 µg/dL), test sensitivity is 100% and the false-positive rate is 23%. Test sensitivity drops to 91%, 63%, and 45% at capillary cutoff values of 0.48, 0.58, and 0.68 µmol/L (10,12, and 14 µg/dL), respectively. The false-positive rate drops to 8%, 2%, and 1% at capillary cutoff values of 0.48, 0.58, and 0.68 µmol/L (10,12, and 14 µg/dL), respectively. Changing the contamination rate by appending or deleting contaminated capillary specimens from the data set had little effect on the area under the ROC curve at either threshold.

Conclusions
In this sample of children, capillary blood lead measurement performed well as a screening test for elevated venous blood lead levels. Altering the capillary specimen contamination rate has little effect on the test characteristics because much of the misclassification error resulted from random analytic error in the analysis of blood lead levels, which is high compared with the threshold of concern (0.48 µmol/L [10 µg/dL]). Because of lack of data on clinical outcomes for children with elevated blood lead levels in the 0.48- to 0.92-µmol/L (10- to 19-µg/dL) range, we suggest that the greatest utility be placed on avoiding false-positive misclassification. A clinical capillary screening cutoff value of 0.72 µmol/L (15 µg/dL) would avoid most false-positive results and would permit 100% sensitivity in detecting children with blood lead levels of 0.97 µmol/L (20 µg/dL) or higher.

Arch Pediatr Adolesc Med. 1996;150:1084-1088



Author Affiliations

From the Department of Pediatrics, Dartmouth Medical School, Hanover, NH.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Interpreting and Managing Blood Lead Levels of Less Than 10 {micro}g/dL in Children and Reducing Childhood Exposure to Lead: Recommendations of the Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention
Binns et al.
Pediatrics 2007;120:e1285-e1298.
ABSTRACT | FULL TEXT  

Diagnostic Testing Unwarranted for Children With Blood Lead 10 to 14 µg/dL
Sargent et al.
Pediatrics 1999;103:51e-51.
ABSTRACT | FULL TEXT  

Evaluation of Risk Assessment Questions Used to Target Blood Lead Screening in Illinois
Binns et al.
Pediatrics 1999;103:100-106.
ABSTRACT | FULL TEXT  

Cost-effectiveness Analysis of Lead Poisoning Screening Strategies Following the 1997 Guidelines of the Centers for Disease Control and Prevention
Kemper et al.
Arch Pediatr Adolesc Med 1998;152:1202-1208.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.